The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

maxim.com.cn

Founded Year

1993

Stage

Corporate Majority - II | Acquired

Total Raised

$116.44M

About MXB Biotechnologies

MXB Biotechnologies focuses on the diagnosis of pathological immunohistochemistry in China. The business covers the following major fields: tumor pathological diagnosis, immunocytochemistry diagnosis, molecular pathological diagnosis, and precision medical diagnosis. The leading products are immunohistochemical detection instruments and a series of reagents.On June 13th, 2020, BSBE acquired a majority stake in MXB Biotechnologies at a valuation of $254.56M.

MXB Biotechnologies Headquarter Location

12F, Haixi Innovation Park Building Gaoxin District, Wulongjiang Middle Blvd.

Fuzhou, Fujian,

China

+86 800-8581156

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing MXB Biotechnologies

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

MXB Biotechnologies is included in 1 Expert Collection, including Cancer.

C

Cancer

3,605 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

  • When was MXB Biotechnologies founded?

    MXB Biotechnologies was founded in 1993.

  • Where is MXB Biotechnologies's headquarters?

    MXB Biotechnologies's headquarters is located at 12F, Haixi Innovation Park Building, Fuzhou.

  • What is MXB Biotechnologies's latest funding round?

    MXB Biotechnologies's latest funding round is Corporate Majority - II.

  • How much did MXB Biotechnologies raise?

    MXB Biotechnologies raised a total of $116.44M.

  • Who are the investors of MXB Biotechnologies?

    Investors of MXB Biotechnologies include BSBE, Sinopharm Investment, CDH Investments, GL Capital, Taikang Life Insurance Company and 3 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.